|
CONTENTS In order of relevance My Study OPCs Diet Stress Talking to Doctors
|
RECENT UPDATES The information below is included here so that frequent visitors to this site can rapidly access new or amended items. The following information has also been added to the appropriate pages throughout this website this month. Items will remain on this page for approximately 8 weeks. My 10 Year Clinical Study Is Now Complete click here to view entire study Pecan Nut ALS mice fed supplementary pecans had a significant delay in decline in motor function compared to mice receiving no pecans. Thomas Shea of the Center for Cellular Neurobiology at the University of Massachusetts in Lowell The use of cannabis for ALS/MND patients has been called for by researchers in Washington (2010). They say that cannabis is a powerful antioxidative and anti-inflammatory agent and has neuroprotective effects. It also has properties applicable to symptom management of ALS/MND, including analgesia, muscle relaxation, bronchodilation, saliva reduction, appetite stimulation and sleep induction. Updates are kept on this page for about two months. A 16 Year Update (April) it is sixteen years since my first formal diagnosis of ALS/MND, see My Story. Also My Clinical Study commenced on 1st April 1997. Within two years my improvement was significant and my remission remains stable, although pecisely what this signifies remains unclear. My Diagnosis should confirm that I was not misdiagnosed. Sixteen years post-diagnosis I am wondering if my over-active inflammatory response, although uncomfortable and often very painful, is offering neuroprotection in my case. As mentioned numerous times on this website, I have suffered no discernable neurodegeneration for over a decade but for that entire time I have suffered inflammatory nerve pain and am medicated accordingly. If ALS/MND is an auto immune illness or has an auto immune component my remission could be partly explained by my body's over-enthusiastic immune system. It responds violently to minor insect bites and stings and I have near constant nerve root Inflammation, more than can be fully explained by my old spinal injuries. Many researchers are now considering that ALS/MND and many other "untreatable" chronic illnesses are caused by "multiple, combined systemic insults", as I proposed many years ago (see My Theory). I hope that researchers can get the funding to better understand the human immune system and the concept that a relatively benign organism may act as a catalyst for another organism (systems or organisms) to act uncharacteristically, damaging the central nervous system. This has been a long time coming. If you agree that ALS/MND may be caused in the way I propose please support researchers working on multi faceted chronic illnesses and research into understanding the Human Immune Response. Steven Shackel 1st April 2010 Oxidative Stress & Neurotoxicity The basic premise of my initial research was that excessive oxidation of neurones was a primary process of neurodegeneration observed in ALS/MND. Whether a cause or a symptom, stopping or even slowing oxidation of neurones seemed a sensible thing to do. That was in 1994. Click here for more recent research and opinions. ALS: A Form Of Sudden, Rapid Aging of The Immune System? One of the first thing I noted in my own research was that neurones in ALS/MND seemed to be suffering from a rapid form of ageing. This led to me experimenting with antioxidents in an attempt to slow that rapid ageing, which took the form of runaway oxidation. This article discusses that possibility. Although Multiple Sclerosis (MS) differs from ALS/MND in many ways it is a form of progressive neurodegeneration and as such we may be able to learn from advances made in MS research. Here is a recent article. A Drug to Treat Neurodegeneration? STEM CELL RESEARCH FOR ALS/MND Biotech company, BrainStorm Cell Therapeutics, are completing pre-clinical trials for the treatment of ALS/MND and have funding to continue research, starting in 2010 and including human trials. Animal trials conducted in Israel proved the efficacy of BrainStorm's technology for transforming stem cells into injectable nerve cells with the aim of curing ALS/MND. Trials were led by Professor Eldad Melamed, former Head of Neurology at Rabin Medical Center, and cell biologist Dr. Daniel Offen, head of the Neuroscience Laboratory at the Felsenstein Medical Research Center of Tel Aviv University. Alphabetical Contents List
|